MedTrace Logo

Effect of Resistance Training on Musculoskeletal Endocrine Interactions

NCT02040727 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2015-04-17

No results posted yet for this study

Summary

This project will evaluate the impact of resistance training on the synthesis and release of hormones and growth factors from the musculoskeletal system and the extent to which the communicative capacity influences glucose homeostasis In turn, the contribution of glucose regulation on the musculoskeletal system will also be evaluated. This small study will serve as a pilot/feasibility study to define a protocol for implementation of a resistance training intervention in the pediatric population. To establish feasibility, this study population is limited to overweight African American boys ages 7-11 years.

In light of well-established accolades of resistance training, historical recommendations for avoidance among the pediatric population have deterred implementation of resistance training interventions in young adolescents. However, contemporary data indicating a profound benefit of resistance training to the skeletal system in pre-adolescents has led to the Academy of Sports Medicine, as well as various other pediatric health interest groups, to support supervised programs incorporating resistance training in young children, emphasizing large muscle and core strengthening. To date, such trials have not been conducted in the pediatric population

Conditions

  • Musculoskeletal and Metabolic Crosstalk

Interventions

BEHAVIORAL

Resistance Training

Supervised strength training 3 days per week for 24 weeks

BEHAVIORAL

No Resistance Training

No supervised strength training throughout the study

Sponsors & Collaborators

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Orlando M Gutierrez, MD, MMSc · University of Alabama at Birmingham

  • Lynae J Hanks, PhD, RD · University of Alabama at Birmingham

  • Krista Casazza, PhD, RD · University of Alabama at Birmingham

  • Marcas Bamman, PhD · University of Alabama at Birmingham

  • Ambika Ashraf, MD · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
7 Years
Max Age
12 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02040727 on ClinicalTrials.gov